Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function

scientific article published on July 2012

Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4103/0975-1483.100020
P932PMC publication ID3483524
P698PubMed publication ID23112533
P5875ResearchGate publication ID232742276

P50authorGurinder SinghQ41650103
P2093author name stringGurinder Singh
Roopa S Pai
V Kusum Devi
P2860cites workPhysical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.Q31674692
Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical reviewQ37260733
Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).Q37920869
Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite designQ41810592
Sintering of wax for controlling release from pelletsQ41989840
Properties of melt extruded enteric matrix pelletsQ43271052
Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteersQ44510249
Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitatesQ44653528
A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronizationQ46557583
Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design".Q51591631
Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with Eudragit.Q52404549
Variable furosemide absorption and poor predictability of response in elderly patients.Q53977479
Design of experiments for capillary electrophoretic enantioresolution of salbutamol using dermatan sulfateQ57010488
Use of Rabbits for GI Drug Absorption Studies: Relationship between Dissolution rate and Bioavailability of Griseofulvin TabletsQ66973917
Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrinQ81160340
Development of extended zero-order release gliclazide tablets by central composite designQ94684009
P433issue3
P304page(s)146-156
P577publication date2012-07-01
P1433published inJournal of Young PharmacistsQ15817278
P1476titleOptimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function
P478volume4

Reverse relations

cites work (P2860)
Q51074380Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Q42840178Development and evaluation of 6-mercaptopurine and metoclopramide polypill formulation for oral administration: In-vitro and ex vivo studies
Q64972547Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
Q89920524Nanocrystals of Fusidic Acid for Dual Enhancement of Dermal Delivery and Antibacterial Activity: In Vitro, Ex Vivo and In Vivo Evaluation
Q89511413Nanoparticle-Mediated Dual Targeting: An Approach for Enhanced Baicalin Delivery to the Liver
Q33800631Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers.
Q55170368Optimization (central composite design) and validation of HPLC method for investigation of emtricitabine loaded poly(lactic-co-glycolic acid) nanoparticles: in vitro drug release and in vivo pharmacokinetic studies.
Q45235236Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine
Q39631063Taste Masked Orally Disintegrating Pellets of Antihistaminic and Mucolytic Drug: Formulation, Characterization, and In Vivo Studies in Human
Q92853421Tripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular System
Q35638055Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging.

Search more.